$1.90
0.158.57%
Pre-Market: 4:35 PM EDT
15 minutes delayed
Comments
Loading...
XORTX Therapeutics
XRTXNASDAQ
XORTX Therapeutics (XRTX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestXORTX Therapeutics (NASDAQ:XRTX) Stock Quotes, Forecast and News Summary
XORTX Therapeutics Stock (NASDAQ: XRTX) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 62.95K |
| Day Range | - - - |
| 52 Wk Range | 1.52 - 609.44 |
| Market Cap | $5.52M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 49 |
| Short Interest | 0.08% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing,...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy XORTX Therapeutics (XRTX) stock?
You can purchase shares of XORTX Therapeutics (NASDAQ:XRTX) through any online brokerage.
Who are XORTX Therapeutics (XRTX) competitors?
There are no as such competitors for XORTX Therapeutics.
What is the target price for XORTX Therapeutics (XRTX) stock?
There is no analysis for XORTX Therapeutics.
What is the forecast for XORTX Therapeutics (XRTX) stock?
XORTX Therapeutics has a consensus price target of $14.00.
Current stock price for XORTX Therapeutics (XRTX)?
The stock price for XORTX Therapeutics (NASDAQ: XRTX) is $1.9 last updated July 23, 2024 at 4:35 PM EDT.
Does XORTX Therapeutics (XRTX) pay a dividend?
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on February 17, 2014 to stockholders of record on January 31, 2014.
When is XORTX Therapeutics (NASDAQ:XRTX) reporting earnings?
XORTX Therapeutics’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
Is XORTX Therapeutics (XRTX) going to split?
There is no upcoming split for XORTX Therapeutics.
What sector and industry does XORTX Therapeutics (XRTX) operate in?
XORTX Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.